These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 15380464)

  • 1. C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosis.
    Zee RY; Hegener HH; Fernandez-Cruz A; Lindpaintner K
    Atherosclerosis; 2004 Oct; 176(2):393-6. PubMed ID: 15380464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 haplotype-based analysis and incidence of post-angioplasty restenosis.
    Zee RY; Cook NR; Kim CA; Fernandez-Cruz A; Lindpaintner K
    Hum Genet; 2004 Mar; 114(4):386-90. PubMed ID: 14740296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 cluster genes and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: a prospective, angiography-based evaluation.
    Zee RY; Fernandez-Ortiz A; Macaya C; Pintor E; Fernandez-Cruz A; Lindpaintner K
    Atherosclerosis; 2003 Dec; 171(2):259-64. PubMed ID: 14644395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysis.
    Zee RY; Hegener HH; Cook NR; Ridker PM
    J Thromb Haemost; 2004 Aug; 2(8):1240-3. PubMed ID: 15304023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate genetic markers and the risk of restenosis after coronary angioplasty.
    Völzke H; Grimm R; Robinson DM; Wolff B; Schwahn C; Hertwig S; Motz W; Rettig R
    Clin Sci (Lond); 2004 Jan; 106(1):35-42. PubMed ID: 12899665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic risk for restenosis after coronary balloon angioplasty.
    Horibe H; Yamada Y; Ichihara S; Watarai M; Yanase M; Takemoto K; Shimizu S; Izawa H; Takatsu F; Yokota M
    Atherosclerosis; 2004 May; 174(1):181-7. PubMed ID: 15135268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
    Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
    Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.
    Shim CY; Park S; Yoon SJ; Park HY; Kim HT; Oh B; Park C; Ko YG; Choi D; Jang Y; Chung N
    Cardiology; 2007; 107(4):261-8. PubMed ID: 16954682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid metabolism and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: role of cholesteryl ester transfer protein and paraoxonase/arylesterase.
    Zee RY; Fernandez-Otiz A; Macaya C; Pintor E; Lindpaintner K; Fernandez-Cruz A
    J Thromb Haemost; 2003 Jun; 1(6):1202-7. PubMed ID: 12871320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha plays an important role in restenosis development.
    Monraats PS; Pires NM; Schepers A; Agema WR; Boesten LS; de Vries MR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; 't Hart LM; Frants RR; Quax PH; van Vlijmen BJ; Havekes LM; van der Laarse A; van der Wall EE; Jukema JW
    FASEB J; 2005 Dec; 19(14):1998-2004. PubMed ID: 16319143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia.
    Suk Danik J; Chasman DI; Cannon CP; Miller DT; Zee RY; Kozlowski P; Kwiatkowski DJ; Ridker PM
    Ann Hum Genet; 2006 Nov; 70(Pt 6):705-16. PubMed ID: 17044845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
    Saleh N; Tornvall P
    Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
    Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty.
    Moatti D; Meirhaeghe A; Ollivier V; Bauters C; Amouyel P; de Prost D
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):317-23. PubMed ID: 11460016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.
    Beijk MA; Boekholdt SM; Rittersma SZ; Pons D; Zwinderman AH; Doevendans PA; Tio RA; Tijssen JG; Jukema JW; de Winter RJ
    Pharmacogenet Genomics; 2010 Sep; 20(9):544-52. PubMed ID: 20671584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin-6 and C-reactive protein genetic polymorphisms levels with venous thromboembolism.
    Mahemuti A; Abudureheman K; Aihemaiti X; Hu XM; Xia YN; Tang BP; Upur H
    Chin Med J (Engl); 2012 Nov; 125(22):3997-4002. PubMed ID: 23158132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
    Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins.
    Hoshida S; Nishino M; Takeda T; Tanouchi J; Yamada Y; Hori M
    Atherosclerosis; 2004 Apr; 173(2):285-90. PubMed ID: 15064103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
    J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.